Pathophysiology of Bisphosphonates associated Osteonecrosis of the Jaw (R01) | Apply Online

Opportunity Summary:

This NIH funding opportunity, titled "Pathophysiology of Bisphosphonates associated Osteonecrosis of the Jaw (R01)" (Funding Opportunity Number PA-07-132), supported Research Project Grant (R01) applications aimed at understanding osteonecrosis of the jaw (ONJ) as an oral complication linked to bisphosphonate therapy. The central focus was on basic and translational research designed to identify, define, and characterize the biological and pathological mechanisms that lead to impaired bone healing in the jaw and ultimately result in ONJ. In practical terms, the opportunity was looking for well-justified projects that could explain why jaw bone tissue, under certain conditions and in certain patients taking bisphosphonates, fails to repair normally and progresses toward necrosis, with the broader goal of generating knowledge that could inform prevention, risk reduction, and more effective clinical management.

The opportunity was jointly issued across multiple NIH institutes with overlapping interests in oral health, skeletal biology, and cancer care: the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and the National Cancer Institute (NCI). That multi-institute sponsorship highlights how ONJ sits at the intersection of dentistry and craniofacial research, bone and connective tissue biology, and oncology, since bisphosphonates are commonly used not only for osteoporosis and other metabolic bone diseases but also to reduce skeletal complications in cancer patients with bone metastases. The listed CFDA numbers reflect those domains: 93.121 (Oral Diseases and Disorders Research), 93.395 (Cancer Treatment Research), and 93.846 (Arthritis, Musculoskeletal and Skin Diseases Research).

As an R01 mechanism, the announcement supported investigator-driven research projects rather than training, infrastructure, or service programs. While the synopsis does not spell out specific experimental approaches, the emphasis on "basic and translational studies" indicates that NIH was encouraging a pipeline from fundamental mechanism (for example, cellular and molecular effects of bisphosphonates on bone remodeling, vascular supply, immune response, or microbial interactions) through to clinically relevant models and observations (such as tissue-based studies, animal models of jaw bone healing, or carefully designed clinical and translational investigations). The overarching deliverable was a clearer pathophysiological explanation of ONJ development, particularly mechanisms that account for impaired healing after dental trauma or oral surgery and the jaw-specific susceptibility that distinguishes ONJ from other skeletal sites.

In terms of eligibility and administrative details, the opportunity was categorized as a discretionary grant with no cost sharing or matching requirement. A wide range of applicants were eligible, including public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (both with and without 501(c)(3) status, as specified), state governments, and additional entities as outlined in the full announcement. Importantly, foreign institutions were explicitly eligible to apply, signaling an openness to international expertise and patient populations relevant to ONJ. The posting date was December 7, 2006, with multiple receipt dates over the life of the program. The current closing date listed was September 7, 2009, and the archive date was October 7, 2009, meaning the announcement is no longer active but remains a useful reference for the type of research priorities NIH had established for this complication.

For full details, NIH directed applicants to the complete program announcement at http://grants.nih.gov/grants/guide/pa-files/PA-07-132.html, and provided NIH Office of Extramural Research (OER) webmaster contact information for access or linking issues.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: The Development Of Frontal Cortex And Limbic System And Their Roles In Drug Abuse Or Mental Health (R01)

Previous opportunity: Health Services Research on Practice Improvement Utilizing Community Treatment Programs within the National Drug Abuse Clinical Trials Network (CTN) (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 07 132

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 07 132) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 132", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.